Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer

André, Thierry; Van Cutsem, Eric; taieb, julien; Fakih, Marwan; Prager, M.D., Gerald; Ciardiello, Fortunato; Tabernero, Josep

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	André, Thierry
dc.contributor.author	Van Cutsem, Eric
dc.contributor.author	taieb, julien
dc.contributor.author	Fakih, Marwan
dc.contributor.author	Prager, M.D., Gerald
dc.contributor.author	Ciardiello, Fortunato
dc.contributor.author	Tabernero, Josep
dc.date.accessioned	2024-11-06T11:25:32Z
dc.date.available	2024-11-06T11:25:32Z
dc.date.issued	2024-10
dc.identifier.citation	André T, Van Cutsem E, Taieb J, Fakih M, Prager GW, Ciardiello F, et al. Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer. Curr Treat Options Oncol. 2024 Oct;25:1312–22.
dc.identifier.issn	1534-6277
dc.identifier.uri	https://hdl.handle.net/11351/12183
dc.description	Teràpia combinada; Eficàcia; Càncer colorectal metastàtic
dc.language.iso	eng
dc.publisher	Springer
dc.relation.ispartofseries	Current Treatment Options in Oncology;25
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Avaluació de resultats (Assistència sanitària)
dc.subject	Recte - Càncer - Tractament
dc.subject	Còlon - Càncer - Tractament
dc.subject	Quimioteràpia combinada
dc.subject.mesh	Colorectal Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Antineoplastic Combined Chemotherapy Protocols
dc.subject.mesh	Treatment Outcome
dc.title	Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1007/s11864-024-01261-w
dc.subject.decs	neoplasias colorrectales
dc.subject.decs	/farmacoterapia
dc.subject.decs	protocolos de quimioterapia antineoplásica combinada
dc.subject.decs	resultado del tratamiento
dc.relation.publishversion	https://doi.org/10.1007/s11864-024-01261-w
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[André T] Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, INSERM 938, SIRIC CURAMUS, Sorbonne University, Paris, France. [Van Cutsem E] Digestive Oncology, University Hospitals Gasthuisberg Leuven, KU Leuven, Leuven, Belgium. [Taieb J] Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Université Paris-Cité, Paris, France. [Fakih M] City of Hope Helford Clinical Research Hospital, Duarte, CA, USA. [Prager GW] Department of Medicine I, AKH Wien, Medical University of Vienna, Vienna, Austria. [Ciardiello F] Division of Medical Oncology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain
dc.identifier.pmid	39325367
dc.identifier.wos	001320094600001
dc.rights.accessrights	info:eu-repo/semantics/openAccess